Literature DB >> 4076159

BCG treatment of periocular sarcoid.

J D Lavach, K E Sullins, S M Roberts, G A Severin, C Wheeler, D C Lueker.   

Abstract

Twenty-six horses and five mules with periocular sarcoids were treated with intralesional injections of a purified bacillus of Calmette and Guerin (BCG) cell walls in oil suspension. All sarcoids were cured and the horses and mules remained free from recurrence of sarcoid during the two-year follow-up period.

Entities:  

Mesh：

Substances：

Year:  1985        PMID： 4076159     DOI： 10.1111/j.2042-3306.1985.tb02552.x

Source DB:  PubMed          Journal:  Equine Vet J        ISSN： 0425-1644            Impact factor:   2.888


  7 in total

1.  Le sarcoïde équin: présentation d'un cas clinique.

Authors:  G Nappert; J P Lavoie; R Sauvageau; D W Scott
Journal:  Can Vet J       Date:  1989-11       Impact factor: 1.008

2.  Periocular sarcoid with bone invasion in a Thoroughbred mare.

Authors:  Andres Giraldo; Chantale L Pinard; Brandon L Plattner; Marie-Soleil Dubois
Journal:  Can Vet J       Date:  2020-04       Impact factor: 1.008

3.  Autologous vaccination for the treatment of equine sarcoids: 18 cases (2009-2014).

Authors:  Caitlin C Rothacker; Ashley G Boyle; David G Levine
Journal:  Can Vet J       Date:  2015-07       Impact factor: 1.008

4.  Carbon dioxide laser as a surgical instrument for sarcoid therapy--a retrospective study on 60 cases.

Authors:  B Carstanjen; P Jordan; O M Lepage
Journal:  Can Vet J       Date:  1997-12       Impact factor: 1.008

5.  Immunotherapy of bovine ocular squamous cell carcinoma by repeated intralesional injections of live bacillus Calmette-Guérin (BCG) or BCG cell walls.

Authors:  V P Rutten; W R Klein; W A De Jong; W Misdorp; P A Steerenberg; W H De Jong; W Den Otter; E J Ruitenberg
Journal:  Cancer Immunol Immunother       Date:  1991       Impact factor: 6.968

6.  Expression of vascular endothelial growth factor (VEGF) in equine sarcoid.

Authors:  Manuela Martano; Karen Power; Brunella Restucci; Ilaria Pagano; Gennaro Altamura; Giuseppe Borzacchiello; Paola Maiolino
Journal:  BMC Vet Res       Date:  2018-09-03       Impact factor: 2.741

7.  ALVAC-fIL2, a feline interleukin-2 immunomodulator, as a treatment for sarcoids in horses: A pilot study.

Authors:  Corey Saba; Randall Eggleston; Andrew Parks; John Peroni; Eric Sjoberg; Shelbe Rice; Jesse Tyma; Jarred Williams; Deborah Grosenbaugh; A Timothy Leard
Journal:  J Vet Intern Med       Date:  2022-04-13       Impact factor: 3.175
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.